Ken Fisher's AZN Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 21.16 M shares of AstraZeneca PLC (AZN) worth $1.62 B, representing 0.59% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in AZN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 9.21 M shares. Largest reduction occurred in Q3 2022, reducing 12.44 M shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2015 | +27,947 | New Buy | 27,947 | $31.81 |
| Q4 2015 | +193,659 | Add 692.95% | 221,606 | $33.95 |
| Q1 2016 | +11,803 | Add 5.33% | 233,409 | $29.71 |
| Q2 2016 | +105,570 | Add 45.23% | 338,979 | $29.97 |
| Q3 2016 | +1.64 M | Add 483.39% | 1.98 M | $32.86 |
| Q4 2016 | -26,586 | Reduce 1.34% | 1.95 M | $27.32 |
| Q1 2017 | -29,907 | Reduce 1.53% | 1.92 M | $31.14 |
| Q2 2017 | +9.16 M | Add 476.85% | 11.08 M | $34.09 |
| Q3 2017 | +519,717 | Add 4.69% | 11.6 M | $33.88 |
| Q4 2017 | +315,759 | Add 2.72% | 11.92 M | $34.70 |
| Q1 2018 | +626,827 | Add 5.26% | 12.54 M | $34.97 |
| Q2 2018 | +535,782 | Add 4.27% | 13.08 M | $35.11 |
| Q3 2018 | +436,783 | Add 3.34% | 13.52 M | $39.57 |
| Q4 2018 | +1.45 M | Add 10.72% | 14.97 M | $37.98 |
| Q1 2019 | +409,357 | Add 2.74% | 15.37 M | $40.43 |
| Q2 2019 | +529,694 | Add 3.45% | 15.9 M | $41.28 |
| Q3 2019 | +357,670 | Add 2.25% | 16.26 M | $44.57 |
| Q4 2019 | +108,747 | Add 0.67% | 16.37 M | $49.86 |
| Q1 2020 | +185,866 | Add 1.14% | 16.56 M | $44.66 |
| Q2 2020 | +370,371 | Add 2.24% | 16.93 M | $52.89 |
| Q3 2020 | +415,735 | Add 2.46% | 17.34 M | $54.80 |
| Q4 2020 | +508,094 | Add 2.93% | 17.85 M | $49.99 |
| Q1 2021 | +537,914 | Add 3.01% | 18.39 M | $49.72 |
| Q2 2021 | +441,805 | Add 2.40% | 18.83 M | $59.90 |
| Q3 2021 | +759,134 | Add 4.03% | 19.59 M | $60.06 |
| Q4 2021 | +520,259 | Add 2.66% | 20.11 M | $58.25 |
| Q1 2022 | +732,959 | Add 3.64% | 20.84 M | $66.34 |
| Q2 2022 | +544,887 | Add 2.61% | 21.39 M | $66.07 |
| Q3 2022 | -12.44 M | Reduce 58.19% | 8.94 M | $54.84 |
| Q4 2022 | -240,500 | Reduce 2.69% | 8.7 M | $67.80 |
| Q1 2023 | +47,644 | Add 0.55% | 8.75 M | $69.41 |
| Q2 2023 | +181,126 | Add 2.07% | 8.93 M | $71.57 |
| Q3 2023 | +239,817 | Add 2.69% | 9.17 M | $67.72 |
| Q4 2023 | +205,185 | Add 2.24% | 9.38 M | $67.35 |
| Q1 2024 | +277,218 | Add 2.96% | 9.65 M | $67.75 |
| Q2 2024 | +302,574 | Add 3.13% | 9.96 M | $77.99 |
| Q3 2024 | +524,175 | Add 5.26% | 10.48 M | $77.91 |
| Q4 2024 | +479,692 | Add 4.58% | 10.96 M | $65.52 |
| Q1 2025 | +9.21 M | Add 83.99% | 20.17 M | $73.50 |
| Q2 2025 | +530,520 | Add 2.63% | 20.7 M | $69.88 |
| Q3 2025 | +466,745 | Add 2.26% | 21.16 M | $76.72 |
Ken Fisher's AstraZeneca PLC Investment FAQs
Ken Fisher first purchased AstraZeneca PLC (AZN) in Q3 2015, acquiring 27,947 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held AstraZeneca PLC (AZN) for 41 quarters since Q3 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to AstraZeneca PLC (AZN) was in Q1 2025, adding 20,165,459 shares worth $1.48 B. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 21,162,724 shares of AstraZeneca PLC (AZN), valued at approximately $1.62 B. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AstraZeneca PLC (AZN) represents approximately 0.59% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in AstraZeneca PLC (AZN) was 21,387,732 shares, as reported at the end of Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.